112 related articles for article (PubMed ID: 2006643)
1. Sex differences in fasting glycemia as a risk factor for ischemic heart disease death.
Scheidt-Nave C; Barrett-Connor E; Wingard DL; Cohn BA; Edelstein SL
Am J Epidemiol; 1991 Mar; 133(6):565-76. PubMed ID: 2006643
[TBL] [Abstract][Full Text] [Related]
2. GHb is a better predictor of cardiovascular disease than fasting or postchallenge plasma glucose in women without diabetes. The Rancho Bernardo Study.
Park S; Barrett-Connor E; Wingard DL; Shan J; Edelstein S
Diabetes Care; 1996 May; 19(5):450-6. PubMed ID: 8732708
[TBL] [Abstract][Full Text] [Related]
3. Sex differences in insulin levels in older adults and the effect of body size, estrogen replacement therapy, and glucose tolerance status. The Rancho Bernardo Study, 1984-1987.
Ferrara A; Barrett-Connor E; Wingard DL; Edelstein SL
Diabetes Care; 1995 Feb; 18(2):220-5. PubMed ID: 7729301
[TBL] [Abstract][Full Text] [Related]
4. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study.
Barrett-Connor EL; Cohn BA; Wingard DL; Edelstein SL
JAMA; 1991 Feb; 265(5):627-31. PubMed ID: 1987413
[TBL] [Abstract][Full Text] [Related]
5. The association of angina pectoris with heart disease mortality among men and women by diabetes status: the Rancho Bernardo Study.
Carpiuc KT; Wingard DL; Kritz-Silverstein D; Barrett-Connor E
J Womens Health (Larchmt); 2010 Aug; 19(8):1433-9. PubMed ID: 20629575
[TBL] [Abstract][Full Text] [Related]
6. Sex differential in ischemic heart disease mortality in diabetics: a prospective population-based study.
Barrett-Connor E; Wingard DL
Am J Epidemiol; 1983 Oct; 118(4):489-96. PubMed ID: 6637976
[TBL] [Abstract][Full Text] [Related]
7. Heart disease risk factors and hormone use in postmenopausal women.
Barrett-Connor E; Brown WV; Turner J; Austin M; Criqui MH
JAMA; 1979 May; 241(20):2167-9. PubMed ID: 430817
[TBL] [Abstract][Full Text] [Related]
8. Sex difference in the effect of the fasting serum glucose level on the risk of coronary heart disease.
Ahn SV; Kim HC; Nam CM; Suh I
J Cardiol; 2018 Feb; 71(2):149-154. PubMed ID: 28882397
[TBL] [Abstract][Full Text] [Related]
9. [Prevalence of type II diabetes mellitus in population of Krakow].
Szurkowska M; Szybiński Z; Nazim A; Szafraniec K; Jedrychowski W
Pol Arch Med Wewn; 2001 Sep; 106(3):771-9. PubMed ID: 11928585
[TBL] [Abstract][Full Text] [Related]
10. The sex differential in mortality from all causes and ischemic heart disease.
Wingard DL; Suarez L; Barrett-Connor E
Am J Epidemiol; 1983 Feb; 117(2):165-72. PubMed ID: 6829546
[TBL] [Abstract][Full Text] [Related]
11. A prospective study of sex hormone-binding globulin and fatal cardiovascular disease in Rancho Bernardo men and women.
Goodman-Gruen D; Barrett-Connor E
J Clin Endocrinol Metab; 1996 Aug; 81(8):2999-3003. PubMed ID: 8768865
[TBL] [Abstract][Full Text] [Related]
12. Do lipids, blood pressure, diabetes, and smoking confer equal risk of myocardial infarction in women as in men? The Reykjavik Study.
Jónsdóttir LS; Sigfússon N; Gudnason V; Sigvaldason H; Thorgeirsson G
J Cardiovasc Risk; 2002 Apr; 9(2):67-76. PubMed ID: 12006913
[TBL] [Abstract][Full Text] [Related]
13. Impact of glucose tolerance status on development of ischemic stroke and coronary heart disease in a general Japanese population: the Hisayama study.
Doi Y; Ninomiya T; Hata J; Fukuhara M; Yonemoto K; Iwase M; Iida M; Kiyohara Y
Stroke; 2010 Feb; 41(2):203-9. PubMed ID: 19940278
[TBL] [Abstract][Full Text] [Related]
14. Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort.
Kanaya AM; Barrett-Connor E; Gildengorin G; Yaffe K
Arch Intern Med; 2004 Jun; 164(12):1327-33. PubMed ID: 15226167
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular disease risk factors prior to the diagnosis of impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a community of older adults.
McPhillips JB; Barrett-Connor E; Wingard DL
Am J Epidemiol; 1990 Mar; 131(3):443-53. PubMed ID: 2301354
[TBL] [Abstract][Full Text] [Related]
16. Fasting hyperinsulinaemia and 2-h glycaemia predict coronary heart disease in patients with type 2 diabetes.
Faghihi-Kashani S; Bonnet F; Hafezi-Nejad N; Heidari B; Aghajani Nargesi A; Sheikhbahaei S; Ebadi M; Esteghamati A
Diabetes Metab; 2016 Feb; 42(1):55-61. PubMed ID: 26531321
[TBL] [Abstract][Full Text] [Related]
17. Glucose-cholesterol interaction magnifies coronary heart disease risk for hypertensive patients.
Cohen HW; Hailpern SM; Alderman MH
Hypertension; 2004 May; 43(5):983-7. PubMed ID: 15037563
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the 1997 and 2003 American Diabetes Association classification of impaired fasting glucose: impact on prevalence of impaired fasting glucose, coronary heart disease risk factors, and coronary heart disease in a community-based medical practice.
Kim SH; Chunawala L; Linde R; Reaven GM
J Am Coll Cardiol; 2006 Jul; 48(2):293-7. PubMed ID: 16843178
[TBL] [Abstract][Full Text] [Related]
19. Fasting, non-fasting glucose and HDL dysfunction in risk of pre-diabetes, diabetes, and coronary disease in non-diabetic adults.
Onat A; Can G; Çiçek G; Ayhan E; Doğan Y; Kaya H
Acta Diabetol; 2013 Aug; 50(4):519-28. PubMed ID: 21769500
[TBL] [Abstract][Full Text] [Related]
20. Plasma triglyceride level and mortality from coronary heart disease.
Criqui MH; Heiss G; Cohn R; Cowan LD; Suchindran CM; Bangdiwala S; Kritchevsky S; Jacobs DR; O'Grady HK; Davis CE
N Engl J Med; 1993 Apr; 328(17):1220-5. PubMed ID: 8464432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
